HTG Molecular Diagnostics, Inc.
HTGMQ · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12 | $10 | $22 | $8 |
| Short-Term Investments | $0 | $12 | $6 | $25 |
| Receivables | $1 | $2 | $2 | $3 |
| Inventory | $1 | $2 | $1 | $1 |
| Other Curr. Assets | $1 | $1 | $1 | $4 |
| Total Curr. Assets | $16 | $27 | $33 | $41 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $0 | $0 |
| Total NC Assets | $2 | $3 | $2 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $18 | $30 | $35 | $45 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $1 | $2 |
| Short-Term Debt | $4 | $6 | $4 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $3 | $2 | $3 |
| Total Curr. Liab. | $8 | $10 | $7 | $9 |
| LT Debt | $4 | $6 | $9 | $8 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $4 | $0 | $5 |
| Total NC Liab. | $4 | $10 | $13 | $12 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $12 | $20 | $21 | $21 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$230 | -$208 | -$191 | -$170 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $235 | $219 | $206 | $194 |
| Total Equity | $5 | $10 | $14 | $24 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $18 | $30 | $35 | $45 |
| Net Debt | -$4 | $2 | -$10 | $4 |